"Butanones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of butanone, also known as methyl ethyl ketone (with structural formula CH3COC2H5).
Descriptor ID |
D002074
|
MeSH Number(s) |
D02.522.296
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Butanones".
Below are MeSH descriptors whose meaning is more specific than "Butanones".
This graph shows the total number of publications written about "Butanones" by people in this website by year, and whether "Butanones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 2 | 0 | 2 |
2005 | 1 | 0 | 1 |
2020 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Butanones" by people in Profiles.
-
Kethoxal-assisted single-stranded DNA sequencing captures global transcription dynamics and enhancer activity in situ. Nat Methods. 2020 05; 17(5):515-523.
-
Keth-seq for transcriptome-wide RNA structure mapping. Nat Chem Biol. 2020 05; 16(5):489-492.
-
The nonsteroidal anti-inflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethane-treated rat models of colon carcinogenesis. Cancer Lett. 2005 Jan 20; 217(2):161-9.
-
Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation. Br J Cancer. 2001 May 18; 84(10):1412-6.
-
Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int J Cancer. 2001 May 15; 92(4):609-15.
-
Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr). J Clin Pharmacol. 1989 Mar; 29(3):225-9.